Abstract
Further understanding of the mechanisms involved in cellular and intracellular delivery of transgene is needed to produce clinical applications of gene therapy. The compartmental and computational model designed in this work is integrated with data from previous experiments to quantitatively estimate rate constants of plasmid translocation across cellular barriers in transgene delivery in vitro. The experimental conditions between two cellular studies were held constant, varying only the cell type, to investigate how the rates differed between cell lines. Two rate constants were estimated per barrier for active transport and passive diffusion. Translocation rates of intact plasmid across the cytoplasmic and nuclear barriers varied between cell lines. CV1 cells were defined by slower rates (0.23 h−1 cytoplasmic, 0.08 h–1 nuclear) than those of the HeLa cells (1.87 h−1 cytoplasmic, 0.45 h−1 nuclear). The nuclear envelope was identified as a rate-limiting barrier by comparing the rate of intact plasmid translocation at each barrier. Slower intact plasmid translocation in CV1 cells was correlated with a reduced absolute capacity for transgene efficiency in comparison with HeLa cells. HeLa cells were three times more efficient than CV1 cells at producing green fluorescent protein per intact plasmid delivered to the nucleus. Mathematical modeling coordinated with experimental studies can provide detailed, quantitative understanding of nonviral gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Phillips AJ . The challenge of gene therapy and DNA delivery. J Pharm Pharmacol 2000; 53: 1169–1174.
Leopold PL . Fluorescence methods reveal intracellular trafficking of gene transfer vectors: the light toward the end of the tunnel. Mol Ther 2000; 1: 302–303.
Schatzlein AG . Nonviral vectors in cancer gene therapy: principles and progress. Anticancer Drugs 2001; 12: 275–304.
Escrious V et al. Cationic lipid-mediated gene transfer: analysis of cellular uptake and nuclear import of plasmid DNA. Cell Biol Toxicol 1997; 14: 95–104.
Lechardeur D et al. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Therapy 1999; 6: 482–497.
Capecchi MR . High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 1980; 22: 479–488.
Boussif O et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine. Proc Natl Acad Sci 1995; 92: 7297–7301.
Farhood H, Serbina N, Huang L . The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta 1995; 1235: 289–295.
Rakhmilevich AL et al. Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12. Hum Gene Ther 1997; 8: 1303–1311.
Canatella PJ, Prausnitz MR . Prediction and optimization of gene transfection and drug delivery by electroporation. Gene Therapy 2001; 8: 1464–1469.
Taniyama Y et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Therapy 2002; 9: 372–380.
Liu F, Song YK, Liu D . Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 1999; 6: 1258–1266.
Cartier R et al. In vivo gene transfer by low-volume jet injection. Anal Biochem 2000; 282: 262–265.
Pouton CW, Seymour LW . Key issues in non-viral gene delivery. Adv Drug Deliv Rev 1998; 34: 3–19.
Plank C, Zauner W, Wagner E . Application of membrane-active peptides for drug and gene delivery across cellular membranes. Adv Drug Deliv Rev 1998; 134: 21–35.
Fajac I, Briand P, Monsigny M, Midoux P . Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells. Hum Gene Ther 1999; 10: 395–406.
Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997–19007.
Brunner S et al. Cell cycle dependence of gene transfer by lipoplex, polyplexes and recombinant adenovirus. Gene Therapy 2000; 7: 401–407.
Tseng W-C, Haselton FR, Giorgio TD . Mitosis enhances transgene expression of plasmid delivered by cationic liposomes. Biochim Biophys Acta 1999; 1445: 53–64.
Ledley TS, Ledley FD . Multicompartment, numerical model of cellular events in the pharmacokinetics of gene therapies. Hum Gene Ther 1994; 5: 679–691.
Varga CM, Hong K, Lauffenburger DA . Quantitative analysis of synthetic gene delivery vector design properties. Mol Ther 2001; 4: 438–446.
James MB, Giorgio TD . Nuclear-associated plasmid, but not cell-associated plasmid, is correlated with transgene expression in cultured mammalian cells. Mol Ther 2000; 1: 339–346.
Chan CK, Jans DA . Using nuclear targeting signals to enhance nonviral gene transfer. Immunol Cell Biol 2002; 80: 119–130.
Nakanishi M et al. Nuclear targeting of DNA. Eur J Pharm Sci 2001; 13: 17–24.
Panté N, Kann M . Nuclear pore complex is able to transport macromolecules with diameters of ∼39 nm. Mol Biol Cell 2002; 13: 425–434.
Stewart M . Nuclear pore structure and function. Semin Cell Biol 1992; 3: 267–277.
Welz C et al. Nuclear transport of oligonucleotides in HepG2-cells mediated by protamine sulfate and negatively charged liposomes. Pharm Res 2000; 17: 1206–1211.
Acknowledgements
This work was supported by the Bioengineering and Environmental Systems Division of the National Science Foundation under Award BES-9902697. We would also like to acknowledge MB James for use of her experimental data on nonviral gene delivery and Dr MI Miga for reviewing this work.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Banks, G., Roselli, R., Chen, R. et al. A model for the analysis of nonviral gene therapy. Gene Ther 10, 1766–1775 (2003). https://doi.org/10.1038/sj.gt.3302076
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302076
Keywords
This article is cited by
-
Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization
Respiratory Research (2014)
-
The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls
Molecular Therapy (2010)
-
Gene Therapy: A Pharmacokinetic/Pharmacodynamic Modelling Overview
Pharmaceutical Research (2010)
-
Quantitative Comparison of Intracellular Unpacking Kinetics of Polyplexes by a Model Constructed From Quantum Dot-FRET
Molecular Therapy (2008)
-
Delivery and mechanistic considerations for the production of knock-in mice by single-stranded oligonucleotide gene targeting
Gene Therapy (2007)